Skip to main content

Mancini Anthony's Form 4 filing

Revolution Medicines, Inc. (RVMD) · filed Sep 14, 2026

Accession no.
0002124509-26-000004
Filed
Sep 14, 2026, 6:03 PM ET
Trade date
Sep 10, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.15M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mancini AnthonyCIK 0002124509Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 10, 2026Common StockMOption exerciseAcquired+9,363$33.62+$314,784.0659,338Direct
Sep 10, 2026Common StockSSaleDisposed−6,019$203.28−$1,223,568.853,319Direct
Sep 10, 2026Common StockSSaleDisposed−5,530$204.14−$1,128,870.4247,789Direct
Sep 10, 2026Common StockSSaleDisposed−2,420$205.05−$496,224.1545,369Direct
Sep 10, 2026Common StockSSaleDisposed−1,179$206.10−$242,991.3144,190Direct
Sep 10, 2026Common StockSSaleDisposed−300$207.17−$62,151.9943,890Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 10, 2026Common StockMOption exerciseDisposed−9,363$0.00$096,746Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)